Nantahala Capital Management, LLC Kura Oncology, Inc. Call Options Transaction History

Nantahala Capital Management, LLC

  • $2.22 Billion
  • Q1 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$10.71 - $18.33 $2.58 Million - $4.42 Million
-240,900 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$11.78 - $16.98 $107,198 - $154,518
-9,100 Reduced 3.64%
240,900 $3.87 Million
Q4 2021

Feb 14, 2022
BUY
$12.22 - $19.57 $3.06 Million - $4.89 Million
250,000 New
250,000 $3.5 Million

Others Institutions Holding KURA

# of Institutions
189
Shares Held
78.6M
Call Options Held
76K
Put Options Held
85.8K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $427M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email